We now have a complementary study that helps extend the picture. If the first paper suggests post-COVID biology may exist on a spectrum, this second one suggests recovery itself may also be real, prolonged, and only partial.🧵
This was a 2 year longitudinal proteomics study of hospitalized COVID survivors. The researchers profiled plasma at 6 months, 1 year, and 2 years after symptom onset and compared it with matched healthy controls.
This cohort was infected in the very early 2020 wave.
The encouraging part is that recovery clearly does happen. The number of differentially expressed proteins fell over time, from 172 at 6 months to 109 at 1 year and 73 at 2 years.
But recovery was not complete, and it was not synchronized. Different pathways normalized on different timelines, which is exactly what you would expect in a layered post infectious condition rather than a simple on/off state.
Some pathways, including focal adhesion, extracellular matrix-receptor interaction, and actin cytoskeleton regulation, improved between 6 months and 1 year.
Other systems appeared to recover more slowly. Cholesterol metabolism shifted closer to control levels between 1 and 2 years, while most immune response pathways - including complement and coagulation - also moved toward, though not necessarily fully back to, control levels before the 2-year mark.
But the reassuring reading would be a mistake. This was not a clean return to baseline. Even after 2 years, some neuron-related signaling pathways remained suppressed, and some oxidative stress-related proteins were still persistently altered. The biology was still carrying damage forward.
And even where parts of the proteomic immune signal moved closer to controls, that should not be mistaken for full recovery. What this study shows is uneven, partial recovery at best - not a complete reset.
That matters because it pushes back against two comforting myths at once. Not only the idea that people either have or don’t have long COVID, but also the idea that recovery is naturally rapid, uniform, or complete.
The picture here is not one of restoration. It is one of prolonged biological disruption, with some systems improving, others lagging, and some still measurably abnormal years later.
And this broader pattern is not without precedent. We have seen in other infections - especially HIV - that biological recovery can remain incomplete long after the acute phase, with persistent effects in immune signaling, oxidative stress, and neuroinflammatory pathways.
It does mean the basic idea is not exotic. An infection can end clinically, while parts of the biology remain dysregulated for much longer.
That is why post-COVID illness may be better understood not as a simple yes/no condition, but as a prolonged and uneven process of partial recovery.
And if 40 years of HIV research still haven’t answered every post-infectious question, the lesson should be obvious. Take non-pharmaceutical prevention seriously and avoid reinfections. Prevention matters far more than people want to admit.
Gu at al., Probing long COVID through a proteomic lens: a comprehensive two-year longitudinal cohort study of hospitalised survivors. thelancet.com/journals/ebiom…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
A new Scientific Reports study adds an important nuance to the long COVID conversation. The biggest difference was not between people with PCC and without PCC, but between uninfected people and everyone who had recovered from SARS2🧵
Long COVID may be part of a broader post-infectious biological spectrum, where symptomatic PCC represents the more clinically visible end of a continuous dysregulation rather than a completely separate category.
That matters, because a lot of people still think in very rigid categories here. But instead of two clean boxes - recovered vs long COVID - the biology may look more like a continuum.
A new study asks a deceptively simple question - is Long COVID just a slower recovery, or is it a persistent immune disorder? Their data point toward the latter !🧵
For this single-cell analysis, the authors selected 9 women from a prospective cohort of patients hospitalized with COVID-19. Blood was collected during acute infection, at 3 months, and again 18-24 months later. Some recovered without long-term complications. Others developed pulmonary or cardiovascular Long COVID.
What makes the paper valuable is not the size of the cohort, but the depth of follow up. The authors profiled peripheral blood mononuclear cells at single-cell resolution and tracked how immune states evolved over time.
A new first trimester study makes an important point. Even when direct detection of SARS-CoV-2 in placental tissue is minimal, the early maternal-fetal environment can still be meaningfully disrupted - immunologically and developmentally🧵
Biological harm does not have to depend on heavy, obvious viral presence inside the tissue itself.
In this study, the authors analyzed a large cohort of 761 first trimester pregnancies. They found only very limited signs of viral RNA in villous and decidual tissue, and no sample was convincingly positive across the main viral targets. That argues against frequent, efficient placental infection.
Very small study, but a genuinely interesting one on long COVID.
After reinfection, the biology did not simply replay the first infection - and in this cohort, the booster did not worsen the measured inflammatory/neurology protein profile🧵
The authors measured 182 inflammatory and neurology related proteins in plasma - 6-9 months after primary infection
after a booster
after breakthrough infection.
In a subset, they had longitudinal samples at 3 timepoints, which makes the paper much more interesting than a simple one time comparison.
It’s small, exploratory, and more hypothesis generating study.
But it asks a very good question.
COVID-19 is not just a story of inflammation. This review argues that it is also a story about what SARS2 does to mitochondria - and how that can turn infection into energy failure, cell injury, and worse oxygenation. This is an important mechanistic review🧵
Mitochondria are not framed here as passive bystanders damaged late in severe illness. In this model, they are active participants in disease - they shape ATP production, ROS, apoptosis, and oxygen sensing.
The review describes two main routes of damage -
very early changes in expression of mito-related genes (hours)
direct interactions between viral proteins and host mito proteins.
So not just the cell is stressed, but a more specific viral rewiring of core cell machinery.
This interesting paper lays out a very specific idea for how severe COVID-19 may be driven not only by the virus itself, but by the way the immune system handles what the virus leaves behind🧵
The starting point is simple.
SARS2 can leave behind viral RNA and nucleocapsid protein (N). N naturally binds viral RNA, and during infection people also make antibodies against N.
The authors build the story from there.
Viral RNA + nucleocapsid (N) + anti-N IgG
= an immune complex carrying viral genetic material.